Cimzia (certolizumab) is a prescription drug used to treat plaque psoriasis, Crohn’s disease, and some types of arthritis, including rheumatoid arthritis. It’s given as an injection under the skin.
(HealthDay)—Cimzia (certolizumab pegol) injection has been approved to treat adults with nonradiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation, the U.S. Food and Drug ...
The Food and Drug Administration (FDA) has approved Cimzia to treat certain inflammatory conditions in adults, including rheumatoid arthritis. It’s also FDA approved for polyarticular juvenile ...
Rheumatoid arthritis (RA) is a type of arthritis that is considered an autoimmune disease. An autoimmune disease is when your immune system starts attacking your body. It causes pain and swelling in ...
A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion from the EMA. UCB developed the AutoClicks ...
Cimzia and Humira are both FDA-approved biologics that treat inflammatory conditions by preventing the immune system from attacking healthy cells. While both medications can cause injection site ...
UCB's CIMZIA® (certolizumab pegol) approved by the U.S. FDA for adult patients suffering from moderate to severe rheumatoid arthritis Available this week, Cimzia® (certolizumab pegol), the only ...
May 27, 2009 — The US Food and Drug Administration (FDA) has approved risperidone long-acting injection for use alone or with lithium or valproate in the treatment of bipolar I disorder; and ...
* EMA has recommended the Cimzia dose dispenser cartridge for use with the re-usable ava electronic injection device in all approved indications Source text: bit.ly/2qcXlVg Further company coverage: ...
Cimzia (certolizumab) is a prescription drug used to treat some types of arthritis and other conditions. Cimzia can cause side effects that range from mild to serious. Examples include infection and ...
ATLANTA, Oct. 18, 2013 -- regulated information – UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Cimzia® (certolizumab pegol) for the treatment of adults with active ...
WASHINGTON The Food and Drug Administration today approved Cimzia, a new drug by UCB to treat Crohn’s disease. Crohn’s disease is a chronic, inflammatory bowel disease. It has no cure and its cause is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results